Phase I Clinical Trial of Suberoylanilide Hydroxamic Acid (SAHA) in Combination With Pemetrexed and Cisplatin in Patients With Advanced Cancer.

Trial Profile

Phase I Clinical Trial of Suberoylanilide Hydroxamic Acid (SAHA) in Combination With Pemetrexed and Cisplatin in Patients With Advanced Cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 12 May 2009

At a glance

  • Drugs Cisplatin; Pemetrexed; Vorinostat
  • Indications Solid tumours
  • Focus Adverse reactions
  • Sponsors Merck & Co
  • Most Recent Events

    • 30 Jul 2008 Status changed from in progress to completed, as reported on clinicaltrials.gov
    • 08 Feb 2008 Status change from recruiting to in progress.
    • 14 Nov 2007 Trial centre added.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top